Both appendicular lean mass and fat mass index accounted for unique variance in motor function after controlling for age in patients with Duchenne muscular dystrophy (DMD). DMD, an inherited disorder ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic lateral sclerosis (ALS), offering new hope for treating the devastating ...

Stroke remains a major global health challenge and a leading cause of adult disability. Rehabilitation aims to restore motor function, enhance independence, and improve quality of life through ...

Scientists traced connectivity between neurons to identify how the brain communicates with the spinal cord to control motor function. Signals relayed to motor neurons from the brain enable muscle ...

The least-squares mean difference in the Hammersmith Functional Motor Scale-Expanded change from baseline at 12 months was 1.8 points for those 2 to 12 years receiving apitegromab vs placebo.

A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic ...

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in ...

Introduction Virtual reality-based telerehabilitation (VR-TR) combines gamified exercises with remote supervision for people with Parkinson’s disease (PD). Its effectiveness and safety in PD remain ...

A Swiss biotechnology firm has restored motor function in mice with Parkinson’s disease, paving the way for human trials later this year. In a presentation at the WORLDSymposium conference earlier ...

Researchers headed by a team at Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health (CAMH) reported promising data from preclinical in vivo studies evaluating a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 30.4% of patients who received apitegromab had a 3-point ...